Eli Lilly’s GLP-1 pill, orforglipron, shows promising trial results for weight loss and type 2 diabetes. Global regulatory approval is planned for 2025.
New GLP-1 pill for weight loss may be closer to reality as drugmaker Eli Lilly says it will file for regulatory approval
Related Posts
-
911 calls reveal confusion delayed emergency help after Christa Pike’s failed execution, reports say
Emergency help for Christa Pike was delayed by confusion among first responders and Tennessee prison…
-
President Trump posts fake quote of Denzel Washington supposedly praising him
President Donald Trump has shared another fake quote on social media, this time a fabricated…
-
Was James Talarico just discharged from ‘mental hospital’? Center denies it, timeline doesn’t fit
Was James Talarico just discharged from a “mental hospital”? The center denies it, and the…
-
Madison County school district warns delayed tax payments could threaten payroll, utilities
MADISON COUNTY, Iowa– All three of Madison County’s school districts are warning they could soon…
Leave a Reply